Niaid preclinical development support: production of alvac-HIV drug product and diluent
Ended Awarded Last action
- Contract number
- 75N93018F00008
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,846,036
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 76% obligated
-
- $6,846,036.00 Current, with exercised options
- $8,997,298.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $6,846,036 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $8,997,298.00 contract supports the production of ALVAC-HIV drug product and diluent as part of NIAID's Preclinical Development Support program. ABL, a contract research and manufacturing organization, specializes in developing biologics such as gene therapies, vaccines, and immunotherapies. The company has over $35 million in prior federal contract experience, including supporting NIH and HHS programs through prime and subcontractor roles for manufacturing, testing, and other product development services.
Quick answers
Who was awarded contract 75N93018F00008?
75N93018F00008 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 11, 2018.
How much is contract 75N93018F00008 worth?
The government has obligated $6,846,036 on 75N93018F00008. Its potential value, with all options, is $8,997,298.
Is contract 75N93018F00008 an order under another contract?
Yes. 75N93018F00008 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93018F00008 competed?
The extent of competition for 75N93018F00008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award